DX Biosciences, Inc. — Form D
DX Biosciences, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-11-16. The offering totals $900K, of which $300K was reported sold. Industry: Other.
Offering
- Filed: 2010-11-16
- Form: D
- Accession: 0001504072-10-000001
- Industry: Other
- Exemptions: 06
- Total offering: $900K
- Amount sold: $300K
- Remaining: $600K
- Investors: 5
- Date of first sale: 2010-10-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-150575
Issuer
- Name: DX Biosciences, Inc.
- CIK: 0001504072
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 10620 TREENA STREET, SAN DIEGO, CA, 92131
- Phone: (713) 622-4880
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Dan Watkins | Director | Houston, TX |
| MyPhuong Lam | Executive Officer | La Jolla, CA |
| Robert Langer | Director | Pittsburgh, PA |
| Daniel Haimovic | Director | New York, NY |
| Samir Mitragotri | Director | San Carlos, CA |
| Russell Lebovitz | Director | San Diego, CA |
| Russell Lebovitz | Executive Officer | San Diego, CA |
| Frank Foster | Director | Santa Barbara, CA |
| Sallie Cassel | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More